These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21628707)

  • 61. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia.
    O'Neill J; Levitt J; Caplan R; Asarnow R; McCracken JT; Toga AW; Alger JR
    Neuroimage; 2004 Apr; 21(4):1781-9. PubMed ID: 15050598
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Whole-brain morphometric study of schizophrenia revealing a spatially complex set of focal abnormalities.
    Davatzikos C; Shen D; Gur RC; Wu X; Liu D; Fan Y; Hughett P; Turetsky BI; Gur RE
    Arch Gen Psychiatry; 2005 Nov; 62(11):1218-27. PubMed ID: 16275809
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Reduced grey and white matter volumes in the temporal lobe of male patients with chronic schizophrenia.
    Okugawa G; Sedvall GC; Agartz I
    Eur Arch Psychiatry Clin Neurosci; 2002 Jun; 252(3):120-3. PubMed ID: 12192469
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Dynamically spreading frontal and cingulate deficits mapped in adolescents with schizophrenia.
    Vidal CN; Rapoport JL; Hayashi KM; Geaga JA; Sui Y; McLemore LE; Alaghband Y; Giedd JN; Gochman P; Blumenthal J; Gogtay N; Nicolson R; Toga AW; Thompson PM
    Arch Gen Psychiatry; 2006 Jan; 63(1):25-34. PubMed ID: 16389194
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of L-theanine on glutamatergic function in patients with schizophrenia.
    Ota M; Wakabayashi C; Sato N; Hori H; Hattori K; Teraishi T; Ozawa H; Okubo T; Kunugi H
    Acta Neuropsychiatr; 2015 Oct; 27(5):291-6. PubMed ID: 25896423
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy.
    Bartha R; Williamson PC; Drost DJ; Malla A; Carr TJ; Cortese L; Canaran G; Rylett RJ; Neufeld RW
    Arch Gen Psychiatry; 1997 Oct; 54(10):959-65. PubMed ID: 9337777
    [TBL] [Abstract][Full Text] [Related]  

  • 67. White-matter microstructure in previously drug-naive patients with schizophrenia after 6 weeks of treatment.
    Wang Q; Cheung C; Deng W; Li M; Huang C; Ma X; Wang Y; Jiang L; Sham PC; Collier DA; Gong Q; Chua SE; McAlonan GM; Li T
    Psychol Med; 2013 Nov; 43(11):2301-9. PubMed ID: 23442742
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Reduced anterior cingulate glutamate in pediatric major depression: a magnetic resonance spectroscopy study.
    Rosenberg DR; Macmaster FP; Mirza Y; Smith JM; Easter PC; Banerjee SP; Bhandari R; Boyd C; Lynch M; Rose M; Ivey J; Villafuerte RA; Moore GJ; Renshaw P
    Biol Psychiatry; 2005 Nov; 58(9):700-4. PubMed ID: 16084860
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Anterior cingulate grey-matter deficits and cannabis use in first-episode schizophrenia.
    Szeszko PR; Robinson DG; Sevy S; Kumra S; Rupp CI; Betensky JD; Lencz T; Ashtari M; Kane JM; Malhotra AK; Gunduz-Bruce H; Napolitano B; Bilder RM
    Br J Psychiatry; 2007 Mar; 190():230-6. PubMed ID: 17329743
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Duration of untreated psychosis vs. N-acetylaspartate and choline in first episode schizophrenia: a 1H magnetic resonance spectroscopy study at 4.0 Tesla.
    Théberge J; Al-Semaan Y; Drost DJ; Malla AK; Neufeld RW; Bartha R; Manchanda R; Menon R; Densmore M; Schaefer B; Williamson PC
    Psychiatry Res; 2004 Jul; 131(2):107-14. PubMed ID: 15313517
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Glutamatergic Response to Heat Pain Stress in Schizophrenia.
    Chiappelli J; Shi Q; Wijtenburg SA; Quiton R; Wisner K; Gaston F; Kodi P; Gaudiot C; Kochunov P; Rowland LM; Hong LE
    Schizophr Bull; 2018 Jun; 44(4):886-895. PubMed ID: 29036718
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Interindividual, repositioning, and time-of-day effects on single voxel proton MR spectroscopy of the anterior cingulate cortex.
    Soreni N; Noseworthy MD; Konyer NB; Pullenayegum E; Schachar R
    J Magn Reson Imaging; 2010 Aug; 32(2):276-82. PubMed ID: 20677251
    [TBL] [Abstract][Full Text] [Related]  

  • 73. 1H-MRS of the anterior cingulate cortex in childhood and adolescent obsessive-compulsive disorder: a case-control study.
    Ortiz AE; Ortiz AG; Falcon C; Morer A; Plana MT; Bargalló N; Lázaro L
    Eur Neuropsychopharmacol; 2015 Jan; 25(1):60-8. PubMed ID: 25499604
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Reality distortion is related to the structure of the salience network in schizophrenia.
    Palaniyappan L; Mallikarjun P; Joseph V; White TP; Liddle PF
    Psychol Med; 2011 Aug; 41(8):1701-8. PubMed ID: 21144116
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder.
    Yücel M; Wood SJ; Wellard RM; Harrison BJ; Fornito A; Pujol J; Velakoulis D; Pantelis C
    Aust N Z J Psychiatry; 2008 Jun; 42(6):467-77. PubMed ID: 18465373
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.
    Abdel-Aziz K; Schneider T; Solanky BS; Yiannakas MC; Altmann DR; Wheeler-Kingshott CA; Peters AL; Day BL; Thompson AJ; Ciccarelli O
    Brain; 2015 Jun; 138(Pt 6):1568-82. PubMed ID: 25863355
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction.
    Plitman E; de la Fuente-Sandoval C; Reyes-Madrigal F; Chavez S; Gómez-Cruz G; León-Ortiz P; Graff-Guerrero A
    Schizophr Bull; 2016 Mar; 42(2):415-24. PubMed ID: 26320195
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Heritability of cerebral glutamate levels and their association with schizophrenia spectrum disorders: a
    Legind CS; Broberg BV; Mandl RCW; Brouwer R; Anhøj SJ; Hilker R; Jensen MH; McGuire P; Pol HH; Fagerlund B; Rostrup E; Glenthøj BY
    Neuropsychopharmacology; 2019 Feb; 44(3):581-589. PubMed ID: 30301944
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre
    Egerton A; Broberg BV; Van Haren N; Merritt K; Barker GJ; Lythgoe DJ; Perez-Iglesias R; Baandrup L; Düring SW; Sendt KV; Stone JM; Rostrup E; Sommer IE; Glenthøj B; Kahn RS; Dazzan P; McGuire P
    Mol Psychiatry; 2018 Nov; 23(11):2145-2155. PubMed ID: 29880882
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies.
    Marsman A; van den Heuvel MP; Klomp DW; Kahn RS; Luijten PR; Hulshoff Pol HE
    Schizophr Bull; 2013 Jan; 39(1):120-9. PubMed ID: 21746807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.